WILD’s know-how and usability experience has helped make Breathe ILO, the unique breathanalyser that determines a woman’s fertile days in a simple, quick and reliable way.

Measuring body temperature every morning or going through unpleasant blood and urine tests are part of the daily routine for many women wishing to conceive. Yet they can never be certain, since the results are subject to fluctuations due to influences such as sports or disease. This creates a situation that puts a significant strain on many couples. Carbomed has now developed Breathe ILO, a unique breath analyser aimed at changing this. It allows the user to determine her fertile days simply on the basis of her breath. The user has to breathe into the convenient mouthpiece for 60 seconds so that the analyser can measure CO2 levels in her breath. Shortly afterwards, the result is shown in a corresponding app.

The WILD Group is a systems partner of Carbomed

Breathe ILO was developed in collaboration with the WILD Group. The latter contributed its know-how in product development, firmware and electronics design, managed the transition to serial production, and has been manufacturing the device since late 2018. “WILD is the ideal partner for us, since they combine both the necessary development and production expertise under one roof”, explain Carbomed co-founders Dr. Horst Rüther and Prof. Ludwig Wildt. WILD’s developers and manufacturing experts sat around the same table from the functional structure to the production-ready solution, allowing for a highly efficient communication. Thanks to their precise analysis of the requirements, they managed to keep production costs as low and quality as high as possible. For instance, they chose not to install a built-in monitor, opting instead for a smartphone screen to display the results.

Safe and user-friendly

Contrary to conventional methods, Breathe ILO is not based on a forecast but precisely detects a woman’s Menstruation cycle. Thanks to this live tracking system, which continuously improves its precision through an AI-based learning algorithm, the device also works with irregular cycles, detecting five out of six fertile days on average. “As a result, we really stand out from the competition”, explains Managing Director Evi Jesacher. Another compelling USP is the device’s simple use. “Users can choose the time of the day they want to perform the test”, Jesacher adds. In a next step, Carbomed plans to seek Registration of Breathe ILO as a medical product. This would render the analyser also suitable for contraception.